PATENT CLAIM ANALYSIS

Application Number: 16000467
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "282000"]

Abstract:
The invention relates to novel strategies for the treatment of cancer patients based on a combination of an opioid receptor agonist and an anticancer compound.

Claim (Index 24):
The method according to  claim 21  wherein the opioid receptor agonist is selected from the group consisting of:\n i. compounds of the methadone group selected from the group consisting of D/L-methadone, D-methadone, L-methadone, and normethadone; \n ii. fentanyl derivatives selected from the group consisting of fentanyl, sufentanyl and carfentanyl; \n iii. morphinane compounds selected from the group consisting of morphine, codeine, heroine, dextrallorphane, dextromethorphan, dextrophanol, dimemorfan, levalorphan, levofurethylnormorphanol, levomethorphane, levophenacylmorphane, levorphanol,methorphane, morphanol, oxilorphan, phenomorphan, and xorphanol; \n iv. benzomorphane derivatives selected from the group consisting of 5,9-DEHB, alazocine, anazocine, bremazocine, butinazocine, carbazocine, cogazocine, cyclazocine, dezocine, eptazocine, etazocine, ethylketocyclazocine, fluorophen, gemazocine, ibazocine, ketazocine, metazocine, moxazocine, pentazocine, phenazocine, quadazocine, thiazocine, tonazocine, volazocine and 8-CAC; \n v. 4-phenylpiperidine derivatives selected from the group consisting of pethidine, ketobemidone, anileridine, piminodine, phenoperidine, furethidine, alpha-prodin, trimeperidine, 4-phenylpyrrolidine derivatives, profadol, 4-phenylazepanderivates, and meptazinol; \n vi. cyclohexane derivatives selected from the group consisting of tilidine, U-50488, tramadol and tapentadol; and \n vii. endogenous opioids selected from the group consisting of endorphins, enkephalins, dynorphins, nociceptin, dermorphins, morphiceptin, endomorphines and fragments derived from the protein proopiomelanocortin (POMC).

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10835511', '13338809', '15920486', '13907035', '14427426']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8000518009460025
- 35 USC 102 Novelty (BERT): 0.5239074003495632
- Combined Prediction Score: 0.7724373608863586
- Mean Citation Score: 292.329026
- Max Citation Score: 308.32446
- Similarity Product: 171.3008025278413

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test